Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetology & Metabolic Syndrome
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Homa-adiponectin index as useful surrogate marker in the screeening of insulin resistance

Authors: Brunna Sullara Vilela, Ana Carolina Junqueira Vasques, Roberta Soares Lara Cassani, Adriana Costa e Forti, José Carlos Pareja, Marcos Antônio Tambascia;, Bruno Geloneze, Investigators BRAMS

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

The major adverse consequences of obesity are associated with the development of insulin resistance (IR) and adiposopathy. The Homeostasis Model Assessment-Adiponectin (HOMA-AD) was proposed as a modified version of the HOMA-IR, which incorporates adiponectin in the denominator of the index. …
Metadata
Title
Homa-adiponectin index as useful surrogate marker in the screeening of insulin resistance
Authors
Brunna Sullara Vilela
Ana Carolina Junqueira Vasques
Roberta Soares Lara Cassani
Adriana Costa e Forti
José Carlos Pareja
Marcos Antônio Tambascia;
Bruno Geloneze
Investigators BRAMS
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A135

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue

Meeting abstract

Precocious endothelial dysfunction in patients with congenital generalized lipodystrophy (Berardinelli-Seip syndrome) evaluated by two different methods

Meeting abstract

Comparison of two techniques for evaluation of pancreatic islet viability: flow cytometry and FDA/PI staining

Meeting abstract

Diabetic and non-diabetic patients in the intensive care unit: morbidity and mortality

Meeting abstract

Evaluation of the acute toxicity oral of carnauba powder (PCO-C) in mice C57BL/6

Meeting abstract

Gain weight and sleep desynchronization in workers of a tertiary hospital

Meeting abstract

Evaluation of serum vitamin b12 in elderly individuals with type 2 diabetes mellitus, with and without dementia, in relation to the use of metformin
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits